Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06609993Completed
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection and bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms). Primary endpoint: Pain perception intraoperatively. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06609993.